CD274 and cancer: Due to the specific function of PD-1/PD-L1 blockage immunotherapy in the field of cancer therapy, PD-1 expression of immune cells was examined independently for PD-1 immune treatment, and the IPS was developed as a marker to distinguish factors in clinical (Kalbasi and Ribas, 2020).